: Naglazyme. ?  »
|
-

I.V

Concentrate For Solution For Infusion

Naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of MPSVI (N-acetylglactosamine 4 sulfatase deficiency Maroteaux-Lamy syndrome).

143 48 31767 00

Biomarin Pharmaceutical Inc, Usa

.
, .
.
/
Galsulfase 1 MG/ML
Vial glass type i 1 x 5 ML 24

*

*

 

.

? !
 »
 
" !
 

, .
:  »
60
, -